Craving Reduction and Smoking Outcomes in Psilocybin-Assisted and Standard Cessation Care

Paper. Strandberg L, Fernandes TP, Shoshina II et al.. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil, 9 Sep 2026.

Tags: Psilocybin, Addiction.

Weekly Science Digest, 5 Sep 2026 to 11 Sep 2026, finding 3: This week's human data

MDMA meta-analysis stays positive; a psilocybin smoking cohort cut craving but not abstinence.

Pooling seven RCTs (published and unpublished, none retracted), MDMA-assisted therapy improved PTSD severity, dissociation, depression and functional impairment, but not sleep. In an observational smoking cohort, psilocybin-assisted care beat standard care on reduction and early urge scores while the adjusted abstinence odds ratio was 1.82 (95% CI 0.68-4.86).

Read the original

—
Node—
Statuslive
Throughput—